William Myers, DO
Family Medicine · Rolla, MONPI 1548232440
Payments from drug & device makers
Across 278 payments — averaging $14.81 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Lilly USA, LLC$487
- AbbVie$396
- Merck$313
- AstraZeneca$299
- Kowa Pharmaceuticals America, Inc.$299
- Amgen$296
- plus $2K from 33 others
What the payments were for
- Food & beverage$4,07199%
- Education$451%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Lilly USA, LLC | 34 | $487 |
| AbbVie(2 entities) | 31 | $396 |
| Merck | 22 | $313 |
| AstraZeneca | 18 | $299 |
| Kowa Pharmaceuticals America, Inc. | 23 | $299 |
| Amgen | 20 | $296 |
| GSK | 22 | $280 |
| Boehringer Ingelheim | 20 | $273 |
| Bayer | 12 | $185 |
| Teva Pharmaceuticals USA, Inc. | 7 | $99 |
| Novo Nordisk | 6 | $96 |
| Takeda Pharmaceuticals U.S.A., Inc. | 6 | $95 |
| Neurocrine Biosciences, Inc. | 4 | $82 |
| Eisai Inc. | 5 | $78 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 4 | $68 |
| Sanofi-aventis U.S. LLC | 4 | $60 |
| Phathom Pharmaceuticals, Inc. | 3 | $55 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 4 | $54 |
| Exact Sciences | 3 | $53 |
| Otsuka America Pharmaceutical, Inc. | 2 | $50 |
| Harmony Biosciences LLC | 1 | $45 |
| Lundbeck LLC | 2 | $39 |
| Pfizer | 3 | $38 |
| Kaleo, Inc. | 1 | $38 |
| Virtus Pharmaceuticals LLC | 2 | $37 |
| Novartis | 2 | $34 |
| Antares Pharma, Inc. | 2 | $34 |
| Valinor Pharma, LLC | 2 | $30 |
| Abbott | 2 | $29 |
| Johnson & Johnson | 2 | $29 |
| Organogenesis Inc. | 1 | $22 |
| Biohaven Pharmaceuticals, Inc. | 1 | $21 |
| Optinose US, Inc. | 1 | $18 |
| Axsome Therapeutics, Inc. | 1 | $17 |
| Apria Healthcare LLC | 1 | $17 |
| Shield Therapeutics Inc | 1 | $14 |
| UCB, Inc. | 1 | $14 |
| Scilex Pharmaceuticals Inc. | 1 | $12 |
| Organon | 1 | $12 |
How this compares
$4,116 in reported general payments places this provider in the 85th percentile of 2,203 family medicine providers in Missouri.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MounjaroTirzepatide | 83 | $99,533 |
| XifaxanRifaximin | 32 | $85,717 |
| OzempicSemaglutide | 85 | $79,735 |
| EliquisApixaban | 107 | $75,534 |
| JardianceEmpagliflozin | 88 | $69,444 |
| JanuviaSitagliptin Phosphate | 64 | $48,233 |
| TrulicityDulaglutide | 51 | $47,998 |
| OxycontinOxycodone Hcl | 29 | $42,956 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 1,390 | $39,831 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 48 | $37,547 |
| Nurtec OdtRimegepant Sulfate | 27 | $32,877 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 50 | $32,785 |
| Janumet XrSitagliptin Phos/Metformin Hcl | 36 | $27,737 |
| Tresiba Flextouch U-200Insulin Degludec | 34 | $26,983 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 1,033 | $23,159 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCMounjaro, Trulicity | $487 | $147,531134 claims |
| PfizerEliquis, Nurtec Odt, Premarin | $38 | $113,704163 claims |
| MerckJanuvia, Janumet Xr, Janumet | $313 | $96,054127 claims |
| Boehringer IngelheimJardiance, Combivent Respimat, Trijardy Xr | $273 | $86,872121 claims |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLCXifaxan | $54 | $85,71732 claims |
| Novo NordiskOzempic | $96 | $79,73585 claims |
| AstraZenecaBreztri Aerosphere, Farxiga, Symbicort, Brilinta, Bevespi Aerosphere | $299 | $76,063129 claims |
| GSKTrelegy Ellipta, Shingrix | $280 | $40,82588 claims |
| AbbVieUbrelvy, Linzess | $396 | $28,58929 claims |
| Otsuka America Pharmaceutical, Inc.Rexulti | $50 | $20,51414 claims |
| NovartisEntresto | $34 | $14,69615 claims |
| BayerKerendia | $185 | $9,49515 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 2,203 family medicine providers in Missouri.
Other family medicine in Rolla
- Omofolarin FasuyiRolla$21K
- Timothy JenningsMaryland Heights$30.2M
- William HowittSpringfield$19.9M
- Rupal TrivediSaint Louis$10.6M
- Frederic PraterMaryland Heights$9.1M
- Leea ReedRogersville$7.9M
- Dennis MorrisonSpringfield$5.7M
- Luke van KirkSpringfield$5.6M
- Amy RobertsTown And Country$4M
- Scott KuennenKansas City$2.2M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.